BetterLife Pharma
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1275 6th Ave W Suite 300, Vancouver, Bri...Phone Number
(646) 679-4321Website
www.abetterlifepharma.comRevenue
-Stock Symbol
BETRIndustry
About BetterLife Pharma
BetterLife Pharma Org Chart
Is BetterLife Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BetterLife Pharma has new funding data
BetterLife Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if BetterLife Pharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at BetterLife Pharma
Product Launch: Get notified when BetterLife Pharma launches new products
Click to see if BetterLife Pharma had a recent Job posting/layoffs
Check if BetterLife Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BetterLife Pharma recently announced quarterly report
Recommended Actions
Find VP level buyers at BetterLife Pharma
Find more new buyers
Compare Similar Companies to BetterLife Pharma
Compare insights from companies similar to BetterLife Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BetterLife Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BetterLife Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BetterLife Pharma.
BetterLife Pharma financials insights
Gather financial insights about BetterLife Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$1.4M
BetterLife Pharma Tech Stack
A closer look at the technologies used by BetterLife Pharma
Most Recent Scoops
BetterLife Pharma News & Media
BetterLife Pharma Announces Appointment of John W. LaRocca to Board of Directors and ...
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"),...BetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND Filing
Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") today announced...BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic neuroplastogen in the treatment of psychiatric and neurological disorders, recently presented a scientific update at Bloom Burton Conference on May 5, 2025 in Toronto, Canada.BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic neuroplastogen in the treatment of psychiatric and neurological disorders, is issuing the following press release in response to British Columbia Securities Commission’s (“BCSC”) May 21, 2025 news release.
Top Business Services Companies
Frequently Asked Questions Regarding BetterLife Pharma
BetterLife Pharma is a biotechnology company focused on discovering and advancing novel therapeutic compounds for psychiatric, neurological, and other medical conditions. Its public materials emphasize drug development around non hallucinogenic psychedelic derived candidates, alongside additional therapeutic programs and a broader pipeline built to... Read More
